8/6/2013 10:20 P.M. ET
Cabrera's suspension creates major hole at short
By Jamal Collier / MLB.com
SAN DIEGO -- The Padres must move forward without their only All-Star this season, now that shortstop Everth Cabrera will miss the final 50 games for violating MLB's Joint Drug Prevention and Treatment Program.
Logan Forsythe will likely get the majority of playing time at shortstop and started there on Tuesday. The Padres also added veteran Ronny Cedeno to the Major League roster on Tuesday after signing him to a Minor League deal Friday.
Cabrera was hitting .283 with a career-high 108 hits in 95 games while leading the National League in steals with 37. The 26-year old ranks fourth among all Major League shortstops in WAR (3.0), so replacing him will be no easy task.
"I think they can handle it," manager Bud Black said. "It's a great opportunity for Logan and the steadiness of Ronny will help."
Forsythe has played six games at shortstop in his career. He's spent time this season at second base, third base and the outfield, and is hitting .209 with four homers and 13 RBIs.
"I'm excited for Logan," Padres third baseman Chase Headley said. "It's an opportunity he's deserved for a long time. ... I like the way he prepares himself and the way he works."
Cedeno was signed as insurance, as he's played parts of nine seasons mostly at shortstop. He spent 51 games with the Astros this season, and hit .220 with six doubles and 12 runs scored, but was designated for assignment on July 22. In two games for Class A Lake Elsinore, he was 1-for-8 with a double, a run scored and two walks.
Cabrera was placed on the restricted list with the suspension, so selecting Cedeno gives the club a full 40-man roster.
Cabrera delivers emotional bilingual pregame speech
SAN DIEGO -- In a closed clubhouse meeting, shortstop Everth Cabrera addressed the Padres prior to Tuesday's game against the Orioles with words that the players described as emotional.
Cabrera was suspended 50 games Monday without pay for violating MLB's Joint Drug Prevention and Treatment Program that will force him to miss the remainder of the 2013 regular season.
Manager Bud Black said Cabrera met with him this past weekend to discuss the details, and it was Cabrera's idea to address the team. He apologized to the Padres, both in English and in Spanish, and expressed remorse much like he did while addressing the media on Monday.
"In one sense you're angry, you're frustrated, you're tired of talking about it," Padres third baseman Chase Headley said. "But on the other hand, you've got a teammate going through a difficult situation, so it's mixed emotions.
"This hurts our team, obviously, so in that respect there may be some of those feelings. But, there's also a feeling of I've been around this guy for four or five years and you can see the emotion that's coming out of him."
Cabrera said on Monday he took a banned substance before or during Spring Training 2012, after the advice of his former representation, Juan Nunez, to help heal a shoulder injury he suffered while playing in Triple-A during the 2011 season.
This isn't the first time the Padres have had to deal with one of their players facing a suspension for using a banned substance. Catcher Yasmani Grandal missed the first 50 games this year for testing positive for elevated levels of testosterone in 2012.
"I think our guys are ready to move on," Black said. "They're conditioned to move past this distraction."
It leaves the Padres without one of their best and most productive players this season. Cabrera, the Padres leadoff man and All-Star, had a career-high 108 hits and led the National League with 37 steals this season.
Black, Headley and outfielder Will Venable all said they are all in favor of stiffer penalties for performance enhancing drugs. Currently, a player receives 50 games for his first violation, 100 for his second and a lifetime ban on the third.
"For whatever reason, 50 games and the shame and embarrassment is still not enough to deter people," Venable said. "I think just as a deterrent, it might be a good idea to increase the penalties. Make people think three or four times about it instead of twice."
Luebke throws first bullpen session since last May
SAN DIEGO -- Left-hander Cory Luebke threw a bullpen session on Tuesday, his first since having reconstructive elbow surgery in May 2012.
Luebke threw around 25 pitches, watched intently by Padres manger Bud Black, who was happy to report that Luebke finished pain-free.
"He looked good and felt fine, so that's a great sign," Black said. "There's been a couple setbacks along the way and that happens, and today was a good sign. It's just another little step, there's still a lot of ground to cover."
This small milestone comes after Luebke experienced a pair of hitches in his recovery. Early in the season, he had his first attempt at a throwing program shut down for about six weeks after he experienced soreness.
Luebke got the point of being able to play catch off the mound in May, but felt some discomfort in his left elbow after a throwing session and was shut down again.
Lubeke will take a couple days off and if he's not feeling any discomfort, will likely throw another bullpen on Thursday or Friday. As he gets closer to participating in full baseball activities, he could go with the Arizona summer league team to participate in their drills and complete his bullpens there.
If he continues to progress along this schedule, Luebke could participate in the instructional league in Arizona beginning in September.
"You hear the 12-to-18 month number," Black said. "Not all of them follow the same path. ... Cory is making progress now, so lets keep our fingers crossed that it continues."
• Carlos Quentin's right knee is still sore and kept him out of the Padres lineup again on Tuesday. Manager Bud Black said there is no timetable for his return and mentioned the possibility of a disabled list stint. Quentin will likely miss Wednesday's game, as well, and with an off-day Thursday, will likely make a decision soon.
Jamal Collier is an associate reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.